Skip to main content
. 2025 Aug 24;15(9):308. doi: 10.1007/s13205-025-04486-0

Table 2.

Predicted ADME and drug-likeness properties (SwissADME) of phenolics from Achillea fragrantissima

Bioavailability radar ADMET properties
3-Caffeoyl-4-feruloylquinic acid graphic file with name 13205_2025_4486_Figa_HTML.gif

• Size: MW = 530.48 g/mol

• Num. H-bond donors:6

• Num. H-bond acceptors: 12

• Flexibility: number of rotatable bonds = 10

• Saturation: fraction Csp3 = 0.27

• TPSA (polarity): 200.28 Å2

• Molar refractivity: 131.37

• Log Po/w = 1.703

• Lipophilicity: XLOGP3 = 6.54

• Solubility: logS (ESOL) = -3.06

• Bioavailability score = 0.55

• BBB permeant: no

• CYP1A2(No), CYP2C19(No), CYP2C9 (No), CYP2D6(No), and CYP3A4(No)

• GI absorption: high

• P-gp substrate: no

• Lipinski (druglikeness): yes; 1 violation: MW > 500

Chlorogenic acid graphic file with name 13205_2025_4486_Figb_HTML.gif

• Size: MW = 354.31 g/mol

• Num. H-bond donors:6

• Num. H-bond acceptors: 9

• Flexibility: number of rotatable bonds = 5

• Saturation: fraction Csp3 = 0.38

• TPSA (polarity): 164.75 Å2

• Molar refractivity: 83.50

• Log Po/w = -0.39

• Lipophilicity: XLOGP3 = -0.42

• Solubility: logS (ESOL) = -1.62

• Bioavailability score = 0.11

• BBB permeant: no

• Log Kp (skin permeation) = -8.76 cm/s

• CYP1A2(No), CYP2C19(No), CYP2C9 (No), CYP2D6(No), and CYP3A4(No)

• GI absorption: high

• P-gp substrate: no

• Lipinski (druglikeness): Yes; 1 violation: NH or OH > 5

Salvianolic acid B graphic file with name 13205_2025_4486_Figc_HTML.gif

• Size: MW = 718.61 g/mol

• Num. H-bond donors:9

• Num. H-bond acceptors: 16

• Flexibility: number of rotatable bonds = 14

• Saturation: fraction Csp3 = 0.17

• TPSA (polarity): 278.04 Å2

• Molar refractivity: 178.07

• Log Po/w = 2.23

• Lipophilicity: XLOGP3 = 3.98

• Solubility: logS (ESOL) = -6.22

• Bioavailability score = 0.11

• BBB permeant: no

• Log Kp (skin permeation) = -7.86 cm/s

• CYP1A2(No), CYP2C19(No), CYP2C9 (No), CYP2D6(No), and CYP3A4(No)

• GI absorption: low

• P-gp substrate: no

• Lipinski (druglikeness): no; 3 violations: MW > 500, N or O > 10, NH or OH > 5